Why BioNTech Crushed the Market on Monday

1 min read

Recently minted biotech industry star BioNTech (NASDAQ: BNTX) was a standout performer on Monday. The stock closed 8.5% higher on the day thanks to very encouraging remarks uttered by its CEO regarding the coronavirus vaccine it’s developed with Pfizer (NYSE: PFE)

As many are aware, BioNTech/Pfizer’s BNT162b2 was recently authorized for emergency use in both the U.S. and European Union. On Monday, the biotech‘s CEO, Dr. Ugur Sahin, made several hopeful pronouncements about it.

Image source: Getty Images.

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

PPP Loan Applications Start Today. Here’s What You Need to Know

Next Story

Carnival Corp & plc (CCL) Q4 2020 Earnings Call Transcript

Latest from Blog